0001179110-20-010225.txt : 20201005 0001179110-20-010225.hdr.sgml : 20201005 20201005161625 ACCESSION NUMBER: 0001179110-20-010225 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20201001 FILED AS OF DATE: 20201005 DATE AS OF CHANGE: 20201005 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Namouni Fouad CENTRAL INDEX KEY: 0001815851 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37359 FILM NUMBER: 201223759 MAIL ADDRESS: STREET 1: 535 BOYLSTON ST., 2ND FLOOR CITY: BOSTON STATE: MA ZIP: 02116 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Blueprint Medicines Corp CENTRAL INDEX KEY: 0001597264 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 45 SIDNEY STREET CITY: CAMBRIDGE STATE: MA ZIP: 02139 BUSINESS PHONE: 617-374-7580 MAIL ADDRESS: STREET 1: 45 SIDNEY STREET CITY: CAMBRIDGE STATE: MA ZIP: 02139 4 1 edgar.xml FORM 4 - X0306 4 2020-10-01 0 0001597264 Blueprint Medicines Corp BPMC 0001815851 Namouni Fouad C/O BLUEPRINT MEDICINES CORPORATION 45 SIDNEY STREET CAMBRIDGE MA 02139 0 1 0 0 President, R & D Common Stock 2020-10-01 4 A 0 32500 0 A 32500 D Stock Option (Right to Buy) 93.93 2020-10-01 4 A 0 65000 0 A 2030-10-01 Common Stock 65000 65000 D The reported transaction involved the Reporting Person's receipt of a grant of 32,500 restricted stock units under the Issuer's 2020 Inducement Plan. This option vests with respect to 25% of the shares underlying the option on October 1, 2021 and as to an additional 1/48th of the shares underlying the option each month thereafter. /s/ Christopher Frankenfield, Attorney-in-Fact 2020-10-05